Security key
02043Q107
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY)
CUSIP: 02043Q107
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 133,131,695
- Total 13F shares
- 119,818,858
- Share change
- +5,226,360
- Total reported value
- $29,121,298,158
- Put/Call ratio
- 92%
- Price per share
- $243.00
- Number of holders
- 514
- Value change
- +$1,425,600,934
- Number of buys
- 271
- Number of sells
- 219
Report period
Q2 2024
Institutions
514
Top holders
10
ALNY full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
ALNYLAM PHARMACEUTICALS, INC. SEC filings
ALNYLAM PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 02043Q107
Recent filing periods:
Top shareholders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
9.6%
|
12,789,236
|
$1,911,351,324 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9%
|
11,994,261
|
$1,792,542,307 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
7.5%
|
9,967,996
|
$1,489,716,967 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.8%
|
9,025,007
|
$1,348,787,295 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.4%
|
7,209,005
|
$1,077,385,798 | — | 31 Mar 2024 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
5%
|
6,623,577
|
$989,893,583 | — | 31 Mar 2024 | |
| DODGE & COX |
13F
|
Company |
2.9%
|
3,811,480
|
$569,625,686 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.8%
|
3,685,753
|
$550,837,000 | — | 31 Mar 2024 | |
| Capital International Investors |
13F
|
Company |
2.7%
|
3,651,217
|
$545,674,307 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
3,191,373
|
$476,950,695 | — | 31 Mar 2024 | |
| Capital Research Global Investors |
13F
|
Company |
2.4%
|
3,144,987
|
$470,018,259 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.2%
|
2,872,904
|
$429,356,000 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
1.7%
|
2,292,654
|
$342,637,140 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
2,001,718
|
$298,724,816 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
1,748,189
|
$261,266,922 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1%
|
1,373,654
|
$205,292,644 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.72%
|
961,504
|
$144,563,313 | — | 31 Mar 2024 | |
| Bellevue Group AG |
13F
|
Company |
0.69%
|
918,284
|
$137,237,544 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
0.63%
|
832,310
|
$124,388,730 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.6%
|
798,445
|
$119,327,470 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.57%
|
758,650
|
$113,380,242 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.56%
|
750,602
|
$112,176,832 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
0.56%
|
746,064
|
$108,298,651 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
739,584
|
$110,530,829 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.51%
|
675,281
|
$100,921,144 | — | 31 Mar 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.44%
|
581,851
|
$86,958,000 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.44%
|
580,441
|
$86,746,907 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.38%
|
511,978
|
$76,515,111 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.38%
|
507,077
|
$75,782,658 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.36%
|
484,893
|
$72,467,260 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.35%
|
462,348
|
$69,097,909 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.34%
|
447,560
|
$66,887,842 | — | 31 Mar 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.3%
|
405,173
|
$60,553,055 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.28%
|
375,900
|
$56,178,255 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.28%
|
374,424
|
$55,959,000 | — | 31 Mar 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
0.27%
|
358,000
|
$53,503,100 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.26%
|
350,000
|
$52,307,500 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.25%
|
337,025
|
$50,368,386 | — | 31 Mar 2024 | |
| ROYAL LONDON ASSET MANAGEMENT LTD |
13F
|
Company |
0.25%
|
326,869
|
$48,850,572 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.24%
|
316,898
|
$47,360,406 | — | 31 Mar 2024 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.23%
|
311,852
|
$46,608,105 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.23%
|
300,000
|
$44,835,000 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.22%
|
290,996
|
$43,489,352 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.22%
|
287,627
|
$42,985,855 | — | 31 Mar 2024 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.21%
|
274,607
|
$41,040,016 | — | 31 Mar 2024 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.21%
|
273,790
|
$40,917,916 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
260,019
|
$38,859,875 | — | 31 Mar 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.19%
|
258,248
|
$39,597,165 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.19%
|
255,179
|
$38,136,502 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.18%
|
244,000
|
$36,465,800 | — | 31 Mar 2024 |
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) as of Q2 2024
As of 30 Jun 2024,
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) was held by
514 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
119,818,858 shares.
The largest 10 holders included
Capital World Investors, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, BAILLIE GIFFORD & CO, Capital International Investors, Dodge & Cox, STATE STREET CORP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
515
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
488
Q2 2024 holders
514
Holder diff
26
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.